As we cross the halfway mark of 2025, the cannabis industry remains a complex, shape-shifting landscape, equal parts promise and pressure. From my vantage point, having helped launch programs across the country and now focused heavily on license acquisition and advisory, the first half of the year was less about flashy wins and more about laying durable groundwork.
What Worked
One of our biggest wins was staying disciplined in strategy. The early months of 2025 were quiet in terms of application volume, but that silence was productive. My team doubled down on legislative engagement, tracked program development across states, and helped shape the early mechanics of upcoming opportunities. It’s not always glamorous work, but it’s the kind that pays off when applications finally drop.
We also refined our marketing approach. Gone are the days of fielding hundreds of calls from aspiring operators with limited capital. Today, our communication is laser-focused on funds and high-capital investors who understand this space isn’t just about cultivation or retail, it’s about regulatory expertise, strategic positioning, and scalable frameworks. This pivot has helped us grow more intentionally and sustainably.
Kentucky deserves a special mention. I’ve worked in nearly every market since cannabis became a legal industry, and Kentucky’s leadership in rolling out their medical program has been among the most competent I’ve seen. From legislation to licensing, they prioritized speed to market and execution over red tape and posturing. It was refreshing and effective.
What Didn’t
Unfortunately, not every state learned from others’ mistakes. Social equity programs in markets like New York and Minnesota continue to struggle. Poorly structured rollouts, inconsistent
funding promises, and unclear guidelines have left many applicants, often from marginalized communities, facing financial risk and regulatory uncertainty. These programs are intended to be lifelines, not landmines. But too often, they’ve become the latter.
Another misstep was assuming traditional sales and marketing tactics would still resonate. Cannabis is maturing, and spray-and-pray approaches no longer cut it. We learned early in the year that planting strategic seeds late in 2024 would have yielded a busier Q1. That gap forced us to recalibrate quickly.
Lessons and Shifts
One of my core strengths is refusing to stay static. Every year, I ask: What needs to evolve? In 2025, that meant revisiting our investor pipeline, restructuring the way we look at new business, and modifying our internal systems for the slower pace of regulatory release.
And while some bet big on equity-based plays, we chose to emphasize “investability.” Programs that place too many restrictions on operators make them less appealing to capital, and that’s a risk we can’t afford in today’s climate.
Looking Ahead
The second half of 2025 is already heating up. Dry states in the South are coming online, and we’re poised to help local leaders develop thoughtful, workable programs. I’m cautiously optimistic that the industry will move toward greater practicality fewer flashy promises, more measurable outcomes.
To fellow operators, my advice is simple: plan thoroughly, keep cash reserves, and never stop innovating. This industry rewards those who adapt. And if you’re not evolving, you’re already falling behind.
